C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 209/04 (2006.01) A61K 31/4045 (2006.01)
Patent
CA 2569238
Compounds of formula I: or pharmaceutically acceptable salts thereof, wherein p, Ar, R1, R2, R3, Ra, Rb, Rc, Rd and Re are defined herein, pharmaceutical compositions containing them and methods of using them for the preparation of medicaments for treating depression or anxiety.
L'invention porte sur des composés de formule (I) ou sur leurs sels acceptables d'un point de vue pharmaceutique, formule dans laquelle p, Ar, R<1>, R<2>, R<3>, R<a>, R<b>, R<c>, R<d> et R<e> sont tels que définis dans le descriptif. L'invention porte également sur des compositions pharmaceutiques contenant ces composés et leurs méthodes d'utilisation dans la préparation de médicaments destinés à traiter la dépression ou l'anxiété.
Greenhouse Robert
Jaime-Figueroa Saul
Raptova Lubica
Reuter Deborah Carol
Stein Karin Ann
Borden Ladner Gervais Llp
F. Hoffmann-La Roche Ag
LandOfFree
3-amino-1-arylpropyl indoles as monoamine reuptake inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-amino-1-arylpropyl indoles as monoamine reuptake inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-amino-1-arylpropyl indoles as monoamine reuptake inhibitor will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1510049